BNET Industries

PURE Bioscience

(PURE) is in the Manufacturing Industry

Market Cap:$55.2M
Last Fiscal Year Sales:$1.4M
  • Public
  • US
Dow Jones Description

PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area).

Number of Employees 15
Contact Information

1725 Gillespie Way

Ste H

El Cajon, California 92020

www.purebio.com

6195968600

NAICS Code Pesticide and Other Agricultural Chemical Manufacturing: 325320

Recent Events

  • Swish and Enviro-Solutions to Launch SDC-Based Disinfectants in Canada and US

    11/24/09 - Joint Venture / Alliance - View Story

  • PURE Bioscience signs agreement with Richmont Sciences

    10/15/09 - Joint Venture / Alliance - View Story

  • BRIEF-Pure Bioscience reports full year results

    10/13/09 - Financial Announcement - View Story

News & Analysis

investment and pure bioscience - All News and Analysis

advertisement
Click Here
     PURE $1.59 -0.08 (-4.78% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 131,469
Shares Outstanding 34.13M
Market Cap 54.3M
Year High 6.25
Year Low 1.22
Earnings Per Share -0.23
P/E Ratio -6.91
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement
Presented by American Express